Find a Tender
complete
Official procurement procedure
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024". Published status: complete. Published value: Value not published. 4 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence ยท Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
46.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 881 active published awards; 872 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published26 Feb 2024, 12:50 GMT | Last source update26 Feb 2024, 12:50 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-040e74 | ||
What is being bought
Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024<br/> <br/>Offer reference number: CM/PHR/22/5678<br/> <br/>CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโs discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโs discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authorityโs discretion) for a period or periods up to a total of 12 months<br/><br/>CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโs discretion) for a period or periods up to a total of 12 months
What changed
From the official release history
- Status changed to complete
26 Feb 2024, 12:50 GMT - Official notice release published
26 Feb 2024, 12:50 GMT - tender value changed
24 Oct 2023, 11:06 BST - Status changed to published status
24 Oct 2023, 11:06 BST - Official notice release published
24 Oct 2023, 11:06 BST - Submission deadline changed to published date
24 Oct 2023, 11:06 BST - Published value updated to ยฃ1,833,333,000
24 Oct 2023, 10:12 BST - Status changed to active
24 Oct 2023, 10:12 BST - Official notice release published
24 Oct 2023, 10:12 BST - Submission deadline changed to 24 Nov 2023, 13:00 GMT
24 Oct 2023, 10:12 BST - Buyer information updated
24 Oct 2023, 10:12 BST
Lots and requirements (4)
Published by the contracting authority
- Lot 1 ยท #1CM/PHR/22/5678/01cancelledPublished valueNot publishedCM/PHR/22/5678/01 - NHS Framework for North of England Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโs discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 ยท #2CM/PHR/22/5678/02cancelledPublished valueNot publishedNHS Framework for North of England Branded Medicines - Lot 2. (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโs discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 ยท #3CM/PHR/22/5678/03cancelledPublished valueNot publishedCM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authorityโs discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 ยท #4CM/PHR/22/5678/04cancelledPublished valueNot publishedCM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโs discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
26 Feb 2024, 12:50 GMT - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Award active
Not published ยท Not published - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1 - Contract active
Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
Commercial outcome and competition
Awards Celltrion Healthcare United Kingdom Limited Not published ยท Not published ยท active Janssen-Cilag Ltd Not published ยท Not published ยท active Eli Lilly and Company Ltd Not published ยท Not published ยท active Roche Products Ltd Not published ยท Not published ยท active Ipsen Not published ยท Not published ยท active Napp Pharmaceuticals Ltd Not published ยท Not published ยท active CST Pharma Limited Not published ยท Not published ยท active Orifarm UK Not published ยท Not published ยท active Teva UK Limited Not published ยท Not published ยท active Novo Nordisk Not published ยท Not published ยท active Novartis Pharmaceuticals UK Ltd Not published ยท Not published ยท active Biogen Not published ยท Not published ยท active Zentiva Pharma UK Ltd Not published ยท Not published ยท active GlaxoSmithKline UK Limited Not published ยท Not published ยท active Celltrion Healthcare United Kingdom Limited Not published ยท Not published ยท active Merck Sharpe and Dohme (UK) Limited Not published ยท Not published ยท active Accord-UK Ltd Not published ยท Not published ยท active Dr.Reddy's Laboratories (UK) Limited Not published ยท Not published ยท active Pfizer Ltd Not published ยท Not published ยท active Aventis Pharma ltd t/a Sanofi Not published ยท Not published ยท active Sun Pharma UK Ltd Not published ยท Not published ยท active Sobi (Swedish Orphan Biovitrum Ltd) Not published ยท Not published ยท active Neon Healthcare Ltd Not published ยท Not published ยท active Galapagos Biotech Ltd Not published ยท Not published ยท active Thornton and Ross Ltd Not published ยท Not published ยท active AstraZeneca Not published ยท Not published ยท active Janssen-Cilag Ltd Not published ยท Not published ยท active Eli Lilly and Company Ltd Not published ยท Not published ยท active Roche Products Ltd Not published ยท Not published ยท active Almirall Not published ยท Not published ยท active Orifarm UK Not published ยท Not published ยท active Teva UK Limited Not published ยท Not published ยท active Novartis Pharmaceuticals UK Ltd Not published ยท Not published ยท active Pfizer Ltd Not published ยท Not published ยท active Gedeon Richter UK Ltd Not published ยท Not published ยท active Amgen Ltd Not published ยท Not published ยท active Accord-UK Ltd Not published ยท Not published ยท active Pfizer Ltd Not published ยท Not published ยท active Sandoz Ltd Not published ยท Not published ยท active Vifor Pharma UK Ltd Not published ยท Not published ยท active Chugai Pharma UK Ltd Not published ยท Not published ยท active Abbvie Ltd Not published ยท Not published ยท active Merck Serono Limited Not published ยท Not published ยท active Janssen-Cilag Ltd Not published ยท Not published ยท active Bayer Plc Not published ยท Not published ยท active Roche Products Ltd Not published ยท Not published ยท active Ipsen Not published ยท Not published ยท active Merz Not published ยท Not published ยท active Napp Pharmaceuticals Ltd Not published ยท Not published ยท active Pharmacosmos UK Ltd Not published ยท Not published ยท active Zentiva Pharma UK Ltd Not published ยท Not published ยท active GlaxoSmithKline UK Limited Not published ยท Not published ยท active Celltrion Healthcare United Kingdom Limited Not published ยท Not published ยท active Merck Sharpe and Dohme (UK) Limited Not published ยท Not published ยท active Accord-UK Ltd Not published ยท Not published ยท active Sandoz Ltd Not published ยท Not published ยท active Dr.Reddy's Laboratories (UK) Limited Not published ยท Not published ยท active Pfizer Ltd Not published ยท Not published ยท active Aventis Pharma ltd t/a Sanofi Not published ยท Not published ยท active Sobi (Swedish Orphan Biovitrum Ltd) Not published ยท Not published ยท active Galapagos Biotech Ltd Not published ยท Not published ยท active Thornton and Ross Ltd Not published ยท Not published ยท active AstraZeneca Not published ยท Not published ยท active Janssen-Cilag Ltd Not published ยท Not published ยท active Eli Lilly and Company Ltd Not published ยท Not published ยท active Roche Products Ltd Not published ยท Not published ยท active Aventis Pharma ltd t/a Sanofi Not published ยท Not published ยท active Organon Pharmaceuticals UK Ltd Not published ยท Not published ยท active Orifarm UK Not published ยท Not published ยท active Teva UK Limited Not published ยท Not published ยท active Novartis Pharmaceuticals UK Ltd Not published ยท Not published ยท active Gedeon Richter UK Ltd Not published ยท Not published ยท active Mylan Not published ยท Not published ยท active Merck Serono Limited Not published ยท Not published ยท active |
Contracts CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B) ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active |
Bid statistics bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) bids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) electronicBids: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromEU: 21 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) smeBids: 4 (lot 2) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) bids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) electronicBids: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromEU: 15 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) smeBids: 5 (lot 3) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) bids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) electronicBids: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromEU: 20 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) smeBids: 4 (lot 4) |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-FTS-3022Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published